These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33172296)

  • 1. Comparison of the Effects of Liraglutide on Islet Graft Survival Between Local and Systemic Delivery.
    Lee SM; Kim D; Kwak KM; Khin PP; Lim OK; Kim KW; Kim BJ; Jun HS
    Cell Transplant; 2020; 29():963689720971245. PubMed ID: 33172296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes.
    Moffett RC; Patterson S; Irwin N; Flatt PR
    Diabetes Metab Res Rev; 2015 Mar; 31(3):248-55. PubMed ID: 25256010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide Protects Pancreatic Islet From Ischemic Injury by Reducing Oxidative Stress and Activating Akt Signaling During Cold Preservation to Improve Islet Transplantation Outcomes.
    Cai X; Cao J; Wang L; Zou J; Li R; Sun P; Ding X; Zhang B; Liu Z; Pei X; Yang J; Zhan Y; Liu N; Liu T; Liang R; Gao J; Wang S
    Transplantation; 2024 Aug; 108(8):e156-e169. PubMed ID: 38578708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.
    Kim SJ; Nian C; Doudet DJ; McIntosh CH
    Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.
    Merani S; Truong W; Emamaullee JA; Toso C; Knudsen LB; Shapiro AM
    Endocrinology; 2008 Sep; 149(9):4322-8. PubMed ID: 18511515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetes.
    Hao T; Zhang H; Li S; Tian H
    Int J Mol Med; 2017 Apr; 39(4):1029-1036. PubMed ID: 28290604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice.
    Millar P; Pathak N; Parthsarathy V; Bjourson AJ; O'Kane M; Pathak V; Moffett RC; Flatt PR; Gault VA
    J Endocrinol; 2017 Sep; 234(3):255-267. PubMed ID: 28611211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preconditioning regimen with a PKCɛ activator improves islet graft function in a mouse transplant model.
    Hamilton D; Rugg C; Davis N; Kvezereli M; Tafti BA; Busque S; Fontaine M
    Cell Transplant; 2014; 23(7):913-9. PubMed ID: 23562311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide and sitagliptin counter beta- to alpha-cell transdifferentiation in diabetes.
    Tanday N; Flatt PR; Irwin N; Moffett RC
    J Endocrinol; 2020 Apr; 245(1):53-64. PubMed ID: 31977315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin administration enhances islet transplant performance in diabetic mice.
    Denroche HC; Quong WL; Bruin JE; Tudurí E; Asadi A; Glavas MM; Fox JK; Kieffer TJ
    Diabetes; 2013 Aug; 62(8):2738-46. PubMed ID: 23656888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial metabolic effects of recurrent periods of beta-cell rest and stimulation using stable neuropeptide Y1 and glucagon-like peptide-1 receptor agonists.
    Tanday N; Lafferty RA; Flatt PR; Irwin N
    Diabetes Obes Metab; 2022 Dec; 24(12):2353-2363. PubMed ID: 35848461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
    Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
    Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4 treatment improves metabolic control after rat islet transplantation to athymic mice with streptozotocin-induced diabetes.
    Sharma A; Sörenby A; Wernerson A; Efendic S; Kumagai-Braesch M; Tibell A
    Diabetologia; 2006 Jun; 49(6):1247-53. PubMed ID: 16609877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice.
    Fan M; Jiang H; Zhang Y; Ma Y; Li L; Wu J
    Med Sci Monit; 2018 Apr; 24():2310-2316. PubMed ID: 29664069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
    Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
    PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamine up-regulates pancreatic sodium-dependent neutral aminoacid transporter-2 and mitigates islets apoptosis in diabetic rats.
    Medras ZJH; El-Sayed NM; Zaitone SA; Toraih EA; Sami MM; Moustafa YM
    Pharmacol Rep; 2018 Apr; 70(2):233-242. PubMed ID: 29475006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The protection of islet β-cells in db/db mice by combination pioglitazone and glucagon like peptide-1 treatment].
    Song LL; Xiao JZ; Yang WY; Zhang M; Liu BB; Pan L
    Zhonghua Nei Ke Za Zhi; 2011 Sep; 50(9):781-4. PubMed ID: 22176969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.
    Patterson S; de Kort M; Irwin N; Moffett RC; Dokter WH; Bos ES; Miltenburg AM; Flatt PR
    Diabetes Obes Metab; 2015 Aug; 17(8):760-70. PubMed ID: 25929155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide Inhibits Osteoclastogenesis and Improves Bone Loss by Downregulating Trem2 in Female Type 1 Diabetic Mice: Findings From Transcriptomics.
    Yu J; Shi YC; Ping F; Li W; Zhang HB; He SL; Zhao Y; Xu LL; Li YX
    Front Endocrinol (Lausanne); 2021; 12():763646. PubMed ID: 34975749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.